BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16265332)

  • 1. Pharmacogenetics: the outlook for genetic testing in statin therapy.
    Chasman DI; Ridker PM
    Nat Clin Pract Cardiovasc Med; 2005 Jan; 2(1):2-3. PubMed ID: 16265332
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenomics of statin response.
    Mangravite LM; Wilke RA; Zhang J; Krauss RM
    Curr Opin Mol Ther; 2008 Dec; 10(6):555-61. PubMed ID: 19051133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic determinants of response to statins.
    Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
    Miltiadous G; Saougos V; Cariolou M; Elisaf MS
    Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomic importance of pravastatin.
    Peters B; Maitland-van der Zee AH
    Pharmacogenomics; 2008 Sep; 9(9):1207-10. PubMed ID: 18781848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When a statin fails.
    Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290
    [No Abstract]   [Full Text] [Related]  

  • 7. More than a statin.
    Underwood A
    Newsweek; 2004 Aug; 144(6):54. PubMed ID: 15449505
    [No Abstract]   [Full Text] [Related]  

  • 8. [Statin cuts cardiovascular risk in half].
    Einecke D
    MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
    [No Abstract]   [Full Text] [Related]  

  • 9. Over-the-counter statin drug.
    Roberts WC
    Am J Cardiol; 2004 Nov; 94(10):1362. PubMed ID: 15541271
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins: not just for the young or the faint of heart.
    Coull BM; Johnston SC
    Neurology; 2009 Feb; 72(8):684-5. PubMed ID: 19237695
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM; Farmer JA
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["No infarct without elevated LDL cholesterol"!].
    Greten H
    MMW Fortschr Med; 2008 Nov; 150(48):119. PubMed ID: 19125517
    [No Abstract]   [Full Text] [Related]  

  • 14. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].
    MMW Fortschr Med; 2005 Nov; 147(45):54. PubMed ID: 16320655
    [No Abstract]   [Full Text] [Related]  

  • 15. Rationale for targeting multiple lipid pathways for optimal cardiovascular risk reduction.
    Ballantyne CM
    Am J Cardiol; 2005 Nov; 96(9A):14K-19K; discussion 34K-35K. PubMed ID: 16291009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [LDL cholesterol in cardiovascular risk patients should be as low as possible].
    MMW Fortschr Med; 2007 Oct; 149(41):44-5. PubMed ID: 17992793
    [No Abstract]   [Full Text] [Related]  

  • 17. Promising therapies for cholesterol reduction.
    Brown WV
    Manag Care; 2002 Sep; 11(9 Suppl):10-4. PubMed ID: 12369337
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease.
    de Lau LM; Stricker BH; Breteler MM
    Mov Disord; 2007 Oct; 22(13):1985. PubMed ID: 17557354
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cholesterol absorption as a target for the treatment of hypercholesterolemia].
    Bitzur R; Cohen H; Harats D
    Harefuah; 2006 Nov; 145(11):831-5, 861, 860. PubMed ID: 17183957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trial.
    de Lemos JA; Wiviott SD; Murphy SA; Blazing MA; Lewis EF; Califf RM; Pfeffer MA; Braunwald E
    Am J Cardiol; 2006 Sep; 98(6):739-42. PubMed ID: 16950174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.